Sector: Health Care
Director information for ABSCI CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Daniel Rabinovitsj | Director; Vice President | 61 | ["Vice President of Meta","Chief Operating Officer of Ruckus Wireless, Inc.","Senior Vice President of Qualcomm Atheros, Inc.","Executive management positions at Atheros Communications, NXP Semiconductors, ST Ericsson, and Silicon Labs","Former board member of QuickLogic Corporation","M.A. in Asian Studies and B.A. in Philosophy from the University of Texas at Austin","Extensive executive, operations and technical expertise"] | [] | 2026 |
| Frans van Houten | Director | 65 | ["Chief Executive Officer and Chair of the Board of Management and Executive Committee of Royal Philips NV","Chief Executive Officer for NXP Semiconductors NV","Extensive executive, corporate strategy and operations expertise"] | [] | 2026 |
| Joseph Sirosh, Ph.D. | Director; CEO and President | 57 | ["CEO and President of CreatorsAGI Inc.","Former Vice President of Amazon's Alexa Shopping group","Former Chief Technology Officer of Compass, Inc.","Various positions at Microsoft Corporation including Chief Technology Officer of Artificial Intelligence","Experience in enterprise database, Big Data, and machine learning","Former Vice President of Technology at Amazon.Com, Inc.","B. Tech in Computer Science and Engineering from IIT Madras","M.S. in Computer Science and Ph.D. in Neural Networks from the University of Texas at Austin"] | [] | 2026 |
| Karen McGinnis | Director | 59 | ["Vice President and Chief Accounting Officer of Illumina, Inc.","Chief Executive Officer and President of Mad Catz Interactive Inc.","Chief Financial Officer of Mad Catz Interactive Inc.","Chief Accounting Officer of Cymer, Inc.","Chief Accounting Officer for Insight Enterprises, Inc.","Senior Vice President of Finance for Insight Enterprises, Inc.","Vice President of Finance for Insight Enterprises, Inc.","Chief Financial Officer of Horizon","Senior Assurance Manager at KPMG LLP","Certified Public Accountant","Bachelor's degree in accounting from the University of Oklahoma"] | [] | 2026 |
| Mary Szela | Director; CEO and President | 62 | ["CEO and President of TriSalus Life Sciences since January 2018","CEO of Aegerion Pharmaceuticals, Inc.","CEO of Novelion Therapeutics Inc.","CEO of Melinta Therapeutics","Held progressive leadership roles at Abbott Laboratories","Developed global brands such as Humira","Senior Vice President for global strategic marketing and services"] | [] | 2026 |
| Prof Sir Menelas Pangalos, Ph.D. | Director | 59 | ["served as a board member of Biogen Inc.","previously served as AstraZeneca's Executive Vice-President of R&D BioPharmaceuticals from January 2019 to March 2024","held senior R&D roles, including Senior Vice President, at Pfizer, Wyeth Research and GlaxoSmithKline","was awarded a knighthood from Her Majesty The Queen of the United Kingdom","holds Honorary Doctorates from Glasgow University and Imperial College, London","is a Fellow of the Royal Society, the Academy of Medical Sciences, the Royal Society of Biology and Clare Hall, University of Cambridge","has taught as a Visiting Professor of Neuroscience at Kings College since 2005","was an Adjunct Professor of Neuroscience from 2007 to 2010 at the Institute of Neurological Sciences at Penn University","received a Ph.D. in Neurochemistry and undergraduate degree in Biochemistry from the University of London","extensive experience in drug discovery, development, research and R&D operations"] | [] | 2026 |
| Ransi Somaratne, M.D., FACC, MBA | Chief Medical Officer | 60 | ["physician-scientist","biopharmaceutical executive","expertise in clinical development","experience at Vertex Pharmaceuticals","lead roles in clinical-stage biotechnology companies","cardiology and internist training","co-authored more than 30 papers"] | [] | 2026 |
| Sean McClain | Founder, Chief Executive Officer and Director | 36 | ["Founder and CEO","strong technical and scientific knowledge","extensive knowledge of our company and industry"] | [] | 2026 |
| Zachariah Jonasson, Ph.D. | Chief Financial Officer and Chief Business Officer | 53 | ["Chief Financial Officer and Chief Business Officer since August 31, 2023","Independent member of the board of directors from October 2020 to December 2023","Board of directors of Absci LLC from April 2016 to October 2020","Managing General Partner of Phoenix Venture Partners LLC","Managing General Partner of Convergent Ventures","Advisor to Convergent Ventures","Director on the boards of L7 Informatics, Inc., Micropore, Inc., Xandar Kardian, Inc., Green Theme Technologies, Inc., and Crop Enhancement, Inc.","Board member of Oregon Translational Research and Development Institute (OTRADI) and Oregon Bioscience Incubator (OBI)","Co-founder and Chief Executive Officer of Comera Life Sciences Holdings, Inc.","Co-founder and VP of Business Development of Crop Enhancement, LLC","General Partner and Kauffman Fellow at Seaflower Ventures","Bachelor of Science from Georgetown University","A.M. and Ph.D. from Harvard University","Cotaught a marketing course at Harvard Business School","Teaching Fellow at Harvard University","Research Associate at the Board of Governors of the Federal Reserve System"] | [] | 2026 |
